What is WO2013171639 (and what does it cover about asciminib synthesis)?
WO2013171639 is a published patent application (WO publication number) that describes chemical compounds and their preparation routes, including disclosure relevant to asciminib (the BCR-ABL1 inhibitor also known as asciminib/ABL001 in earlier development). Patent documents of this type typically include reaction schemes, intermediate definitions, and examples that can be used to synthesize the disclosed compounds.
However, I don’t have the text of WO2013171639 (the claims, examples, and synthetic steps) in the information provided here, so I can’t reliably reproduce or walk through the specific asciminib synthesis procedure from that patent without risking errors or omissions.
Where can you read the exact asciminib synthesis steps from WO2013171639?
To get the real synthesis instructions (the actual starting materials, reagents, conditions, workups, and purification described in the patent), the key is to open the published document itself and review:
- the “Examples” section (where step-by-step preparations are usually given),
- the “Scheme” figures (showing transformations of intermediates), and
- any “Preparations”/“Intermediates” subsections.
If you share the relevant excerpt (or the example numbers you’re interested in), I can help interpret what each step is doing and how the intermediates map to asciminib.
How can you share what you need (so I can help accurately)?
If your goal is to understand or verify the synthesis route, paste one of the following:
- the specific “Example” text for the step that leads toward asciminib,
- the relevant reaction scheme image text (or a screenshot converted to text),
- the claim or intermediate definition that you think corresponds to asciminib.
Then tell me your intent:
- “I want a high-level explanation of the route,” or
- “I want the key transformations and intermediates identified,” or
- “I’m trying to match this to asciminib (ABL001) and confirm which intermediates correspond.”
Is there a DrugPatentWatch.com page for this patent or asciminib synthesis?
DrugPatentWatch.com often tracks drugs and patent families (including exclusivity and certain patent references), but I can’t confirm which specific WO family members match WO2013171639 from the limited prompt alone. If you want, I can look up asciminib’s patent landscape on DrugPatentWatch.com once you confirm whether you mean:
- WO2013171639 specifically, or
- a broader patent family that includes WO2013171639.
---
Sources
None cited (WO2013171639 content was not provided in the prompt, and I don’t have access to the underlying patent text from your message).